Polymorphisms of CD16A and CD32 Fcγ receptors and circulating immune complexes in Ménière's disease: A case-control study

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Lopez Escamez, José A ^a,b   Saenz Lopez, Pablo ^c   Gazquez, Irene ^a,c   Moreno, Antonia ^c   Gonzalez Oller, Carlos ^a   Soto Varela, Andrés ^d   Santos, Sofía ^d   Aran, Ismael ^e   Perez Garrigues, Herminio ^f   Ibañez, Águeda ^a   Lopez Nevot, Miguel A ^c  

^a HOSPITAL DE PONIENTE   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e Complejo Hospitalario de Pontevedra ^*  (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FC RECEPTOR 3A; FC RECEPTOR IIA; UNCLASSIFIED DRUG; FCGR2A PROTEIN, HUMAN; FCGR3A PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; IMMUNE COMPLEX DEPOSITION; MAJOR CLINICAL STUDY; MALE; MENIERE DISEASE; PHENOTYPE; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNE DISEASE; BLOOD; CLINICAL TRIAL; GENETICS; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY;

ADULT; AGED; ANTIGEN-ANTIBODY COMPLEX; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MENIERE DISEASE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTORS, IGG;

EID: 78650777049     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-2     Document Type: Article

References (38)

1. Brand O, Gough S, Heward J. HLA, CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity?. Expert Rev Mol Med 2005, 7:1-15. 10.1017/S1462399405009981, 16229750.
2. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979, 88:585-9.
3. Tebo AE, Szankasi P, Hillman TA, Litwin CM, Hill HR. Antibody reactivity to heat shock protein 70 and inner ear-specific proteins in patients with idiopathic sensorineural hearing loss. Clin Exp Immunol 2006, 146:427-32. 10.1111/j.1365-2249.2006.03227.x, 1810414, 17100761.
4. Harris JP, Weisman MH, Derebery JM, et al. Treatment of corticosteroids-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA 2003, 290:1875-83. 10.1001/jama.290.14.1875, 14532316.
5. Amor-Dorado JC, Paco L, Martin J, Lopez-Nevot MA, Gonzalez-Gay MA. Human leukocyte antigen- DQB1 and -DRB1 associations in patients with idiopathic sudden sensorineural hearing loss from a defined population of northwest Spain. Acta Otolaryngol 2005, 125:1277-1282. 10.1080/00016480510012228, 16303674.
6. Hughes GB, Kinney SE, Barna BP, et al. Autoimmune reactivity in Menière's disease: a preliminary report. Laryngoscope 1983, 93:410-417.
7. Yoo TJ, Shea J, Ge X, et al. Presence of autoantibodies in the sera of Meniere's disease. Ann Otol Rhinol Laryngol 2001, 110:425-9.
8. Fattori B, Nacci A, Dardano A, et al. Possible association between thyroid autoimmunity and Ménière's disease. Clin Exp Immunol 2008, 152:28-32. 10.1111/j.1365-2249.2008.03595.x, 2384067, 18241228.
9. Lopez-Escamez JA, Saenz-Lopez P, Acosta L, et al. Association of a functional polymorphism of PTPN22 encoding a lymphoid protein phosphatase in bilateral Meniere's disease. Laryngoscope 2010, 120:103-7. 10.1002/lary.21310, 19780033.
10. Xenellis J, Morrison AW, McClowskey D, Festenstein H. HLA antigens in the pathogenesis of Ménière's disease. J Laryngol Otol 1986, 100:21-24. 10.1017/S0022215100098698, 3456006.
11. Arweiler DJ, Jahnke K, Grosse-Wilde H. [Ménière's disease as an autosome dominant hereditary disease]. Laryngorhinootologie 1995, 74:512-515. 10.1055/s-2007-997791, 7575905.
12. Koyama S, Mitsuishi Y, Bibee K, Watanabe I. HLA associations with Meniére disease. Acta Otolaryngol (Stockh) 1993, 113:575-578.
13. Yeo SW, Park S, Jeon E, Lee HY, Pyo CW, Ki TG. Influence of human leucocyte antigen in the pathogenesis of Meniere's disease in the south korean population. Acta Otolaryngol 2002, 122:851-56. 10.1080/003655402/000028046, 12542204.
14. Lopez-Escamez JA, Vilchez JR, Soto-Varela A, et al. HLA-DRB1*1101 allele may be associated with bilateral Meniere's disease in southern european population. Otol Neurotol 2007, 28:891-5.
15. Brookes GB. Circulating immune complexes in Meniere's disease. Arch Otolaryngol Head Neck Surg 1986, 112:536-540.
16. Derebery MJ, Rao VS, Siglock TJ, Linthicum FH, Nelson RA. Meniere's disease: an immune complex-mediated illness?. Laryngoscope 1991, 101:225-229.
17. Van Sorge NM, Van der Pol W-L, Van de Winkel JGJ. Fcγ polymorphisms: implication for function, disease susceptibility and immunotherapy. Tissue Antigen 2003, 61:189-202.
18. Van der Pol WL, vande Winkel JGJ. IgG receptor polymorphisms: risk factors for disease. Immunogenetics 1998, 48:222-32. 10.1007/s002510050426, 9683667.
19. Wu J, Edberg JC, Redecha PB. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997, 100:1059-70. 10.1172/JCI119616, 508280, 9276722.
20. Parren PW, Warmerdam PA, Boeije LC, et al. On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils and platelets. Analysis of a functional polymorphism to human IgG2. J Clin Invest 1992, 90:1537-46. 10.1172/JCI116022, 443201, 1401085.
21. Nieto A, Caliz R, Pascual M, Matarán L, Garcia S, Martin J. Involvement of Fcγ receptor IIIA genotypes in susceptibility to rheumatoid arthritis. Arthritis Rheum 2000, 43:735-9. 10.1002/1529-0131(200004)43:4<735::AID-ANR3>3.0.CO;2-Q, 10765917.
22. Morgan AW, Griffiths B, Ponchel F, et al. Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups. Arthritis Rheum 2000, 43:2328-34. 10.1002/1529-0131(200010)43:10<2328::AID-ANR21>3.0.CO;2-Z, 11037893.
23. Dijstelbloem HM, Bijl M, Fijnheer R, et al. Fcgamma receptor polymorphisms in systemic lupus erythematous: association with disease and in vivo clearance of immune complexes. Arthritis Rheum 2000, 43:2793-800. 10.1002/1529-0131(200012)43:12<2793::AID-ANR20>3.0.CO;2-6, 11145038.
24. Edberg JC, Langefeld CD, Wu J, et al. Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus. Arthritis Rheum 2002, 46:2132-40. 10.1002/art.10438, 12209518.
25. Committee on Hearing and Equilibrium Guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg 1995, 113:181-185. 10.1016/S0194-5998(95)70102-8, 7675476, Committee on Hearing and Equilibrium.
26. Aksu K, Kitapcioglu G, Keser G, et al. FcgammaRIIa, IIIa and IIIb gene polymorphisms in Behcet's disease: do they have any clinical implications?. Clin Exp Rheumatol 2008, 4(Suppl 50):S77-83.
27. Van der Pol WL, van der Berg LH, Scheepers RH, et al. IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barre syndrome. Neurology 2000, 54:1661-5.
28. Cines DB, McMillan R. Pathogenesis of chronic immune thrombocytopenic purpura. Curr Opin Hematol 2007, 14:511-4. 10.1097/MOH.0b013e3282ba5552, 17934360.
29. Raknes G, Skeie GO, Gilhus NE, Aadland S, Veleder C. FcgammaRIIA and FcgammaRIIIB polymorphisms in myasthenia gravis. J Neuroimmunol 1998, 81:173-6. 10.1016/S0165-5728(97)00174-4, 9521619.
30. Robertson NG, Lu L, Heller S, et al. Mutations in a novel Cochlear gene cause DFNA9, a human nonsyndromic deafness with vestibular dysfunction. Nat Genet 1998, 20:299-303. 10.1038/3118, 9806553.
31. Fransen E, Verstreken M, Verhagen WI, et al. High prevalence of symptoms of Meniere's disease in three families with a mutation in the COCH gene. Hum Mol Genet 1999, 8:1425-1429. 10.1093/hmg/8.8.1425, 10400989.
32. Sanchez E, Lopez-Escamez JA, Lopez-Nevot MA, Lopez-Nevot A, Cortes R, Martin J. Absence of COCH mutations in patients with Meniere disease. Eur J Hum Gen 2004, 12:75-8.
33. Savastano M, Giacomelli L, Marioni G. Non-specific immunological determinations in Meniere's disease: any role in clinical practice?. Eur Arch Otorhinolaryngol 2007, 264:15-19. 10.1007/s00405-006-0147-2, 17033831.
34. Perez Garrigues H, Carmona E, Morera C, Sanchez-Cuenca JM. Circulating auto-antibodies in Meniere's disease. Ann Otolaryngol Chir Cervicofac 1995, 112:225-228.
35. Hausler R, Arnorld W, Schfferlic J. C3 and C1q complement deposits in the membranous labyrinth of patients with Meniere's disease. Adv Otorhinolaryngol 1988, 42:116-122.
36. Yazawa Y, Kitahara M. Immunofluorescent study of the endolymphatic sac in Meniere's disease. Acta Otolaryngol (Stockh) 1989, 468(Suppl):71-76.
37. Salt AN. Regulation of endolymphatic fluid volume. Ann NY Acad Sci 2001, 942:306-312. 10.1111/j.1749-6632.2001.tb03755.x, 11710472.
38. Shinomori Y, Kimura RS, Adams JC. Changes in immunostaining for Na+, K+, 2Cl-cotransporter 1, taurine and c-Jun N-terminal kinase in experimentally induced endolymphatic hydrops. ARO Abstract 2001, 24:134.